Share.

    13 commenti

    1. MrReadilyUnready on

      Fuck big pharma. They’re still profiting at the price the NHS buys at, otherwise they wouldn’t be selling them anything. Greedy fucks.

      One massive benefit of the NHS that most don’t consider is the sheer bargaining power of having a single body negotiate and purchase drugs for an entire nation.

    2. rev-fr-john on

      They’re not purely investing in, they’re profiting from, and in a big way.

    3. general_adm_aladdeen on

      Would someone please think of the shareholders?!11

    4. Agreeable_Falcon1044 on

      No they won’t. They are butthurt they can’t rip us off like they can the Americans…but let’s be clear, only a complete moron would abandon 70 million customers because they only make “substantial profits” rather than “criminal profits”

    5. NoYouCantHavePudding on

      Literally legal blackmail for greedy shareholders. It’s the American way to do business. Send them packing and steal their recipes.

    6. Captain_English on

      They pulled out of a £450M investment after Labour said they wouldn’t fund it, and they’re threatening not to spend £250M on a new research site at Cambridge.

      This is then mixed in with the AZ chief complaining about the NHS pricing structure, without articulating at all how the NHS pricing approach is in any way bad for the NHS or taxpayers. All we get is:

      >Mr Grady said: “We’ve failed to keep pace on medicine investment over the years.”

      >He accused the Government of falling behind other countries when it comes to supporting innovation and warned that patients were missing out on cutting-edge treatments as a result.

      How are they missing out? 

      This absolutely reads like a company playing hardball with the government on new industrial investment because they want to make more money from the taxpayer. Don’t give in, or they’ll do it again (and so will others).

    7. Innocuouscompany on

      I’ve said it before, make a drugs division of the NHS that then competes against these companies globally. It could tie into education and the industrialisation of science as a national industry.

      It’s the only way to make the NHS affordable in the future as we become an aging population that needs more and more drugs

    8. citron_bjorn on

      We could do with having our own laws allowing other companies to use drug patents if the cost is too high, like india does.

    9. marmarama on

      How about we nationalise AstraZeneca? It’s based in the UK and most of its employees and operations are in the UK.

      If they want to attempt to play hardball with the government over NHS medicine payments, the government should have its own stick for negotiations.

    10. Asking the government to support innovation is one thing; claiming that the only way to do this is to pay US prices is absolutely another.

      And ridiculous.

      The NHS is huge buyer & in a free market is perfectly in its rights to throw its weight around for better pricing.

    11. This is a game, they have been trying to infiltrate and dismantle the NHS for decades.

    12. Rincewindcl on

      Forgive my ignorance, but I’ve always thought that this type of research should be in a public body anyway. When profit is a factor, how can you really trust the outcome of a clinical trial or drugs study? 

      We should have a public body specifically for drug creations and trials. The output could be quite lucrative to sell internally, if the government wants it to generate a profit. 

    Leave A Reply